DEEPTECH

Prezzo DEEPEXI TECH 01384.HK

DEEPTECH
$0
+$0(0,00%)
Nessun dato

*Data last updated: 2026-05-04 13:50 (UTC+8)

As of 2026-05-04 13:50, DEEPEXI TECH 01384.HK (DEEPTECH) is priced at $0, with a total market cap of --, a P/E ratio of 0,00, and a dividend yield of 0,00%. Today, the stock price fluctuated between $0 and $0. The current price is 0,00% above the day's low and 0,00% below the day's high, with a trading volume of --. Over the past 52 weeks, DEEPTECH has traded between $0 to $0, and the current price is 0,00% away from the 52-week high.

DEEPTECH Key Stats

P/E Ratio0,00
Dividend Yield (TTM)0,00%
Shares Outstanding0,00

DEEPEXI TECH 01384.HK (DEEPTECH) FAQ

What's the stock price of DEEPEXI TECH 01384.HK (DEEPTECH) today?

x
DEEPEXI TECH 01384.HK (DEEPTECH) is currently trading at $0, with a 24h change of 0,00%. The 52-week trading range is $0–$0.

What are the 52-week high and low prices for DEEPEXI TECH 01384.HK (DEEPTECH)?

x

What is the price-to-earnings (P/E) ratio of DEEPEXI TECH 01384.HK (DEEPTECH)? What does it indicate?

x

What is the market cap of DEEPEXI TECH 01384.HK (DEEPTECH)?

x

What is the most recent quarterly earnings per share (EPS) for DEEPEXI TECH 01384.HK (DEEPTECH)?

x

Should you buy or sell DEEPEXI TECH 01384.HK (DEEPTECH) now?

x

What factors can affect the stock price of DEEPEXI TECH 01384.HK (DEEPTECH)?

x

How to buy DEEPEXI TECH 01384.HK (DEEPTECH) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su DEEPEXI TECH 01384.HK (DEEPTECH)

CryptoFrontier

CryptoFrontier

04-30 08:12
China's decision to unwind Meta's US$2 billion acquisition of Manus has created significant uncertainty for AI founders with Chinese roots building operations outside their home country, according to reporting by Tech in Asia. The January announcement that China was investigating the deal—citing concerns that Chinese AI intellectual property was being transferred to a US company—prompted some founders to postpone funding announcements and request geographic repositioning of their companies to avoid regulatory scrutiny. ## Founder Response and Caution The ruling has triggered defensive measures among startup leaders. One founder with Chinese origins postponed going public with funding received by his Singapore-based startup to avoid potential misperception by Chinese officials. Another Chinese founder explicitly requested that Tech in Asia describe their company as "Singapore-based," emphasizing that the firm was built from scratch in Singapore with a product intended for the "global market." Amit Verma, founding head of technology at US-based Neuron7.ai, characterized the situation bluntly: "The announcement was the message. Everything after that was just enforcement." ![](https://img-cdn.gateio.im/social/moments-650fddae8f-6f1e7918aa-8b7abd-badf29) *China's ruling to unwind a closed deal sets a precedent for Chinese founders looking to exit outside their home country. / Photo credit: Tada Images / Shutterstock* ## Relocation No Longer a "Silver Bullet" Jeremy Ang, co-founder and CEO of Singapore-based Axium Industries, stated that China's decision demonstrates "the growing complexity for AI firms operating across borders." He emphasized: "Moving headquarters is no longer a silver bullet for bypassing the national security concerns of major powers." While Ang believes Singapore will become an "increasingly attractive" AI hub where founders can build corporate structures navigating "tech-stack decoupling" between the US and China, the Manus case demonstrates that complete relocation is insufficient. Manus relocated its headquarters and laid off its entire China team, yet the fact remained that its product was built entirely in China using local resources—the core issue that triggered regulatory intervention. ## Manus as Strategic Outlier Denis Kalinin, founder of cross-border investment advisory firm DeepTech Asia, cautioned against overgeneralizing from the Manus case. He identified specific factors that made Manus an outlier: it "attracted significant media attention, involved alleged irregularities in transferring IP from China to Singapore without proper approvals, and ended in an acquisition by a US strategic buyer." Kalinin pointed to several other China-related cross-border AI and robotics companies that successfully exited through M&A or public listings without incident. Manus possessed the components to raise potential national security concerns—namely, the combination of Chinese-developed IP, relocation without proper approvals, and acquisition by a US strategic buyer. Tobias Leong, co-founder and CTO of Axium Industries, framed the broader implication: AI talent and IP are now viewed as "core national assets," comparable to semiconductors or energy reserves. "This isn't just about a single deal," he noted. "It's about the new rules of engagement for the global AI ecosystem." ## Conditions That May Protect Other Startups Several sources interviewed by Tech in Asia expressed confidence that founders starting in Singapore would not face similar treatment to Manus. A Singapore-based AI startup with Chinese co-founders stated it did not share Manus's conditions because it was incorporated in Singapore and never employed anyone in Mainland China. The company has received funding from global investors and positions its product for the global market. ![](https://img-cdn.gateio.im/social/moments-99611dc1b7-903a7c1940-8b7abd-badf29) *Image credit: Timmy Loen* ## Investor Implications and Due Diligence Shifts Kalinin distinguished between investor types: those with long-term conviction in China versus opportunistic capital. Opportunistic investors are likely to be deterred by the regulatory risk, lacking deep familiarity with China's regulatory environment necessary to assess risk. Investors remaining active in China will intensify due diligence, focusing on corporate structures, IP ownership, and where IP is actually created. "Clear evidence that core IP is developed and held outside China will become increasingly important," Kalinin stated. With Western strategic acquisitions now facing higher regulatory risk, companies may increasingly pursue Hong Kong IPOs or seek strategic buyers from China and geopolitically aligned regions such as the Middle East or Southeast Asia. ## Strategic Compliance Approaches Amit Verma of Neuron7.ai emphasized that founders are no longer negotiating—they are adapting to what he termed "sovereign risk" rather than normal business risk. One practical approach cited by an AI startup founder in Singapore involves establishing separate entities for global and China-only operations. In this structure, data collected from customers "won't stay in the same server and won't transmit between servers internally and externally," ensuring that global operations do not rely on anything built by the Chinese entity. Verma provided broader context: "The US controls the hardware. China controls regulatory leverage and local ecosystems. Everyone else is now navigating between the two."
0
0
0
0